Bendle G - Search Results

1

Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model.

van Leeuwen AC, Buckle T, Bendle G, Vermeeren L, Valdés Olmos R, van de Poel HG, van Leeuwen FW. van Leeuwen AC, et al. Among authors: bendle g. J Biomed Opt. 2011 Jan-Feb;16(1):016004. doi: 10.1117/1.3528027. J Biomed Opt. 2011. PMID: 21280910 Free article.

2

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN. de Witte MA, et al. J Immunol. 2008 Aug 15;181(4):2563-71. doi: 10.4049/jimmunol.181.4.2563. J Immunol. 2008. PMID: 18684947 Free PMC article.

3

T-cell receptor gene therapy: critical parameters for clinical success.

Linnemann C, Schumacher TN, Bendle GM. Linnemann C, et al. Among authors: bendle gm. J Invest Dermatol. 2011 Sep;131(9):1806-16. doi: 10.1038/jid.2011.160. Epub 2011 Jun 16. J Invest Dermatol. 2011. PMID: 21677669 Free article. Review.

4

Blockade of TGF-β signaling greatly enhances the efficacy of TCR gene therapy of cancer.

Bendle GM, Linnemann C, Bies L, Song JY, Schumacher TN. Bendle GM, et al. J Immunol. 2013 Sep 15;191(6):3232-9. doi: 10.4049/jimmunol.1301270. Epub 2013 Aug 12. J Immunol. 2013. PMID: 23940272

5

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy.

Bendle GM, Linnemann C, Hooijkaas AI, Bies L, de Witte MA, Jorritsma A, Kaiser AD, Pouw N, Debets R, Kieback E, Uckert W, Song JY, Haanen JB, Schumacher TN. Bendle GM, et al. Nat Med. 2010 May;16(5):565-70, 1p following 570. doi: 10.1038/nm.2128. Epub 2010 Apr 18. Nat Med. 2010. PMID: 20400962

6

Induction of unresponsiveness limits tumor protection by adoptively transferred MDM2-specific cytotoxic T lymphocytes.

Bendle GM, Holler A, Pang LK, Hsu S, Krampera M, Simpson E, Stauss HJ. Bendle GM, et al. Cancer Res. 2004 Nov 1;64(21):8052-6. doi: 10.1158/0008-5472.CAN-04-0630. Cancer Res. 2004. PMID: 15520215

7

A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.

Morris EC, Tsallios A, Bendle GM, Xue SA, Stauss HJ. Morris EC, et al. Proc Natl Acad Sci U S A. 2005 May 31;102(22):7934-9. doi: 10.1073/pnas.0500357102. Epub 2005 May 20. Proc Natl Acad Sci U S A. 2005. PMID: 15908507 Free PMC article.

8

Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.

Bendle GM, Holler A, Downs AM, Xue SA, Stauss HJ. Bendle GM, et al. Expert Opin Biol Ther. 2005 Sep;5(9):1183-92. doi: 10.1517/14712598.5.9.1183. Expert Opin Biol Ther. 2005. PMID: 16120049 Review.

9

Preclinical development of T cell receptor gene therapy.

Bendle GM, Haanen JB, Schumacher TN. Bendle GM, et al. Curr Opin Immunol. 2009 Apr;21(2):209-14. doi: 10.1016/j.coi.2009.02.007. Epub 2009 Mar 25. Curr Opin Immunol. 2009. PMID: 19321326 Review.

10

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.

Wright GP, Notley CA, Xue SA, Bendle GM, Holler A, Schumacher TN, Ehrenstein MR, Stauss HJ. Wright GP, et al. Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19078-83. doi: 10.1073/pnas.0907396106. Epub 2009 Nov 2. Proc Natl Acad Sci U S A. 2009. PMID: 19884493 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page